August is not yet half over and already the FDA has had a busy summer.
In recent weeks MobiHealthNews reported on the FDA's de novo clearance of Proteus Digital Health's intelligent medicine platform and Asthmapolis' inhaler sensor and companion software. As we noted early last month, the FDA granted 510(k) clearance to a variety of digital health companies in June, including the app-enabled...
